Mr. Rajnish Ohri reports

TILRAY EXPANDS UK PHARMACEUTICAL ACCESS THROUGH STRATEGIC AGREEMENT WITH SMARTWAY PHARMACEUTICALS

Tilray Pharma's (the pharmaceutical division of Tilray Brands Inc.) European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with Smartway Pharmaceuticals, a leading United Kingdom-based pharmaceutical distribution partner, to expand the availability of pharmaceutical products across the United Kingdom.

Through this agreement, CC Pharma and Smartway will jointly support the expansion of parallel import and specialist pharmaceutical supply in the U.K., leveraging Smartway's established national distribution infrastructure to facilitate the delivery of pharmaceutical products and CC Pharma's European procurement capability and good manufacturing practice capacity, marking a notable advancement in Tilray's comprehensive European medical expansion strategy.

The U.K. pharmaceutical market is estimated at nearly pounds sterling1 billion within this category, and this agreement positions Tilray and CC Pharma to work with Smartway to accelerate access, improve supply reliability and expand reach through trusted health care channels.

Rajnish Ohri, president, international, Tilray Brands, stated: "The U.K. is a priority market within Tilray's international medical strategy. This agreement strengthens our ability to broaden access to medicinal products through established health care distribution channels, while advancing our long-term growth across Europe's evolving medical landscape. Further, this agreement is expected to embed Tilray into the U.K. health system for its own medicinal cannabis products."

CC Pharma and Smartway Pharmaceuticals share a long-standing relationship dating back to 2009, built on cross-border pharmaceutical collaboration and trusted supply chain execution. This new agreement represents the next phase of that relationship, aligned with increasing demand for specialized medical distribution services and expanded product availability in the U.K.

Mathias Bossen, managing director of CC Pharma, added: "This agreement represents an important step forward in expanding our pharmaceutical distribution activities into the U.K. By working closely with Smartway and leveraging their strong national network, we are well positioned to enhance supply reliability and support pharmacy and hospital partners with high-quality PI product lines across the U.K."

Josh Cocklin, chief executive of Smartway, said: "Our focus is always on patients and outcomes. By extending what Smartway already does in regulated pharmaceutical supply, this agreement supports continuity and expansion of access to medicines across U.K. health care. For patients and the health care practitioners who care for them, this means fewer interruptions and more predictable access to care."

Both companies will also explore additional opportunities for broader collaboration over time, supporting Tilray's strategy of building scaled, partnership-led platforms in key international healthcare markets.

About CC Pharma

CC Pharma is a leading pharmaceutical distributor in Germany, serving pharmacies nationwide with a broad portfolio of branded and generic medicines. As part of Tilray Brands, CC Pharma combines local market expertise with the scale, discipline and strategic resources of a global organization.

About Tilray Medical

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, Symbios and Navcora. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the largest suppliers of medical cannabis to patients, physicians, hospitals, pharmacies, researchers and governments in 20 countries and across five continents.

About Tilray Brands Inc.

Tilray Brands is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.

We seek Safe Harbor.